 Ardelyx Inc NASDAQ: ARDX shares are trading higher by 29.32 at 0.97 after the company reported it received an interim response from the OND, CDER and FDA for the companys second level of appeal of the Complete Response Letter for XPHOZAH. Ardelyx says the OND intends to direct the. 